My watch list
my.bionity.com  
Login  

Advance Lot Release and In-process Testing of Biologics in QC

Comprehensive technical and service support for Octet® users in GxP environments

Dr. Helge Schnerr

Selected application areas of Octet® systems in biotherapeutics development.

ForteBio’s Octet® systems meet a wide range of throughput needs. The Octet HTX and RED384 systems analyze either 96 or 16 samples at a time (top). The Octet K2 and RED96e systems analyze either 2 or 8 samples in parallel (bottom).

ForteBio’s Octet® systems utilize BLI technology to monitor biomolecular interactions in real time and label-free. They are an ideal replacement for ELISA and HPLC techniques for the quantification of antibodies and recombinant proteins and are especially suitable for product potency lot release assays. The plate-based and fluidic-free format also offers GMP users distinct advantages over comparative SPR based techniques. Octet systems provide higher throughput with the flexibility to run 2 to 96 samples simultaneously and better sample versatility, including the ability to analyze crude samples and more tolerance to diverse sample matrices. In addition, ease of use, low maintenance and high data precision speeds time to results throughout the drug development process.

This whitepaper describes the Octet platform for reliable and routine use under GxP regulations and particular in QC laboratories.

Facts, background information, dossiers
  • biochemical kinetics
  • kinetic analysis
  • antigen-antibody reaction
  • protein-protein interaction
  • validation
  • impurities
  • residue analysis
  • FDA 21 CFR Part 11
  • biolayer interferometry
  • interferometry
  • binding kinetics
  • binding affinity
  • active ingredients
More about Molecular Devices
  • News

    Molecular Devices and Cytena Partner collaborate in single cell printing

    Molecular Devices, LLC announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This system utilizes microfluidics-based technology and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for us ... more

    Molecular devices wins patent case in Europe

    Molecular Devices, LLC announced that its European Patent No. 1802752 titled “Parallel Patch Clamp System” was upheld by the European Patent Office in its original form, following a recent Opposition Proceeding.    Molecular Devices’ patent went through Opposition Proceedings before the Opp ... more

  • Companies

    Molecular Devices (UK) Limited

    Transform your protein and cell biology research As one of the world’s leading providers of innovative analytical instruments and reagents for life science research, pharmaceutical and biotherapeutic development, we are empowering scientists to unravel the complexity of cell and prote more

    Molecular Devices, LLC

    At Molecular Devices we have one focus -- our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dee ... more

    Molecular Devices GmbH

    more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE